Company Information

VINEET LABORATORIES LTD.

NSE : VINEETLABBSE : 543298ISIN CODE : INE505Y01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE54.95-0.7 (-1.26 %)
PREV CLOSE ( ) 55.65
OPEN PRICE ( ) 55.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 54.90 (112)
VOLUME 685
TODAY'S LOW / HIGH ( )54.95 55.00
52 WK LOW / HIGH ( )45.65 88.95
NSE54.55-1.1 (-1.98 %)
PREV CLOSE( ) 55.65
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 165
TODAY'S LOW / HIGH( ) 54.55 55.65
52 WK LOW / HIGH ( )44.65 88.9
ChairmanDilip Vishnu Acharekar
Managing DirectorGaddam Venkata Ramana
Company SecretaryRameshkumar Bandari
Executive DirectorSatish Pandurang Samant
Non Executive DirectorAlluri Ranga Raju
Non Executive Independent DirectorBhaskara Reddy Karna
Hari Priya Yerukalapudi
Whole Time DirectorSatyanarayana Raju Bhupathiraju
Incorporation Year : 10-11 2016

Registered Office :

Address : Sy.no. 11/ A3, Eshwaramma Nilayam,Saheb Nagar Kurudu V I L L,Chintalkunta, L B Nagar Hyderabad,
Telangana-500074 .

Phone : 040-24128833

Email :  info@vineetlabs.co.in 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.